Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits
Abstract
Background We recently showed that administration of the combination of the noradrenergic drug atomoxetine plus the antimuscarinic oxybutynin (ato-oxy) prior to sleep greatly reduced OSA severity, likely by increasing upper airway dilator muscle activity during sleep. In patients with OSA who performed the ato-oxy trial with an esophageal pressure catheter to estimate ventilatory drive, the effect of the drug combination (n = 17) and of the...
Paper Details
Title
Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits
Published Date
Jun 1, 2020
Journal
Volume
157
Issue
6
Pages
1626 - 1636
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History